We used descriptive analyses of annual cross-sectional data from 2001 through 2010 to examine direct-to-consumer
advertising (DTCA) (Kantar Media) and provider-targeted promotion (IMS Health and SDI), including: (1) inflationadjusted
total promotion spending ($ and percent of sales); (2) distribution by channel (consumer v. provider); and (3)
provider specialty both for the industry as a whole and for top-selling biologic and small molecule therapies